COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 949: Articles 9481-9490  | Next

Validation of a clinical and genetic model for predicting severe COVID-19
Dite, G. S., Murphy, N. M., Spaeth, E., Allman, R., Lifelines Corona Research Initiative
10.1101/2022.01.14.22269270 — Posted: 2022-01-15
Students as Community Vaccinators: Implementation of a Service-Learning COVID-19 Vaccination Program
Griswold, A. R., Klein, J., Dusaj, N., Zhu, J., Keeler, A., Abramson, E. L., Gurvitch, D.
10.1101/2022.01.14.22269312 — Posted: 2022-01-14
Simple risk scores to predict hospitalization or death in outpatients with COVID-19
Ebell, M., Hamadani, R., Kieber-Emmons, A.
10.1101/2022.01.14.22269295 — Posted: 2022-01-14
High-cited favorable studies for COVID-19 treatments ineffective in large trials
Ioannidis, J. P. A.
10.1101/2022.01.11.22269097 — Posted: 2022-01-14 Discussion: Onsite
Evaluation and modelling of the performance of an automated SARS-CoV-2 antigen assay according to sample type, target population and epidemic trends
Yin, N., Debuysschere, C., Daubie, V., Hildebrand, M., Martin, C., Curac, S., Ponthieux, F., Payen, M.-C., Vandenberg, O., Hallin, M.
10.1101/2022.01.14.22269064 — Posted: 2022-01-14
SARS-CoV-2 Omicron Neutralization After Heterologous Vaccine Boosting
Lyke, K. E., Atmar, R. L., Dominguez Islas, C. P., Posavad, C. M., Szydlo, D., PaulChourdhury, R., Deming, M. E., Eaton, A., Jackson, L. A., Branche, A. R., El Sahly, H. M., Rostad, C. A., Martin, J. M., Johnston, C., Rupp, R. E., Mulligan, M. J., Brady, R. C., Frenck, R. W., Bäcker, M., Kottkamp, A. C., Babu, T. M., Rajakumar, K., Edupuganti, S., Dobrzynski, D., Coler, R. N., Archer, J. I., Crandon, S., Zemanek, J. A., Brown, E. R., Neuzil, K. .M., Stephens, D. S., Post, D. J., Nayak, S. U., Roberts, P. C., Beigel, J., Montefiori, D.
10.1101/2022.01.13.22268861 — Posted: 2022-01-14
The risk of SARS-CoV-2 Omicron variant emergence in low and middle-income countries (LMICs)
Bi, K., Herrera-Diestra, J. L., Bai, Y., Du, Z., Wang, L., Gibson, G., Johnson-Leon, M., Fox, S., Meyers, L. A.
10.1101/2022.01.14.22268821 — Posted: 2022-01-14
The emergence of two distinct SARS-CoV-2 Gamma related variants during the second wave of COVID-19 in Santa Catarina, Southern Brazil and the rapid spread of P.1-like-II SARS-CoV-2 variant transmission and a regionalization in the Western region
Padilha, D. A., Benetti-Filho, V., Moreira, R. S., Soratto, T. S. T., Maia, G. A., Christoff, A. P., Barazzetti, F. H., Schorner, M. A., Ferrari, F. L., Martins, C. L., Kawagoe, E. K., Wachter, J. K., Sacchet, P., Baptistella, A., Schlindwein, A. D., Coelho, B. K., Fernandes, S. B., Rovaris, D. B., dos Anjos, M. P. D., Melo, F. R., Bittencourt, B., da Cunha, S., Meneghetti, K. L., Wendt, N., Madaloz, T. Z., Rodrigues, M. V. D., Souza, D. S. M., de Moraes, M. H., Baptista, R. d. P., Toledo-Silva, G., Razzera, G., Grisard, E. C., Stoco, P. H., de Oliveira, L. F. V., Bazzo, M. L., Fongaro, G., Wagner, G.
10.1101/2022.01.13.22268697 — Posted: 2022-01-14
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections: a survival analysis
Hussey, H., Davies, M.-A., Heekes, A., Williamson, C., Valley-Omar, Z., Hardie, D. R., Korsman, S., Doolabh, D., Preiser, W., Maponga, T., Iranzadeh, A., Wasserman, S., Schreuder, N., Boloko, L., Symons, G., Raubenheimer, P., Viljoen, B., Solomon, W., Rousseau, P., Parker, A., Wolter, N., Cohen, C., JASSAT, W., Lessels, R., Wilkinson, R. J., Boulle, A., Hsiao, N.-y.
10.1101/2022.01.13.22269211 — Posted: 2022-01-14
Algorithmic Fairness and Bias Mitigation for Clinical Machine Learning: Insights from Rapid COVID-19 Diagnosis by Adversarial Learning
Yang, J., Soltan, A. A., Yang, Y., Clifton, D. A.
10.1101/2022.01.13.22268948 — Posted: 2022-01-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).